Matinas BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.About MTNB
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access.
CEOJerome D. Jabbour
CEOJerome D. Jabbour
Employees7
Employees7
HeadquartersBedminster, New Jersey
HeadquartersBedminster, New Jersey
Founded2013
Founded2013
Employees7
Employees7
MTNB Key Statistics
Market cap4.16M
Market cap4.16M
Price-Earnings ratio-0.19
Price-Earnings ratio-0.19
Dividend yield—
Dividend yield—
Average volume31.34K
Average volume31.34K
High today$0.6663
High today$0.6663
Low today$0.65
Low today$0.65
Open price$0.65
Open price$0.65
Volume1.54K
Volume1.54K
52 Week high$3.09
52 Week high$3.09
52 Week low$0.4748
52 Week low$0.4748
Stock Snapshot
With a market cap of 4.16M, Matinas BioPharma(MTNB) trades at $0.65. The stock has a price-to-earnings ratio of -0.19.
During the trading session on 2026-01-13, Matinas BioPharma(MTNB) shares reached a daily high of $0.67 and a low of $0.65. At a current price of $0.65, the stock is 0.0% higher than the low and still -2.4% under the high.
Trading volume for Matinas BioPharma(MTNB) stock has reached 1.54K, versus its average volume of 31.34K.
Over the past 52 weeks, Matinas BioPharma(MTNB) stock has traded between a high of $3.09 and a low of $0.47.
Over the past 52 weeks, Matinas BioPharma(MTNB) stock has traded between a high of $3.09 and a low of $0.47.
People also own
Based on the portfolios of people who own MTNB. This list is generated using Robinhood data, and it’s not a recommendation.